Bat Liquid
Product Images NDC 60492-0075

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bat (NDC 60492-0075). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Emergent Biosolutions Canada Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vial Label (Em)

This is a description of a medication called "BAT®" which is a botulism antitoxin used only by the Strategic National Stockpile. It is only for intravenous use and must be stored below -15°C. The medication does not contain any preservatives and is manufactured in Winnipeg, Canada by Emergent BioSolutions Canada Inc. BAT® is a registered trademark of Emergent BioSolutions Inc. or its subsidiaries. The medication should be administered as per the package insert. The lot number is listed as 10028k3.*

FDA Label Image

50cc Carton Label (Image 02)

This is a description of a medication called BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)-(EQUINE)] which is only for use in the Strategic National Stockpile. It contains no preservatives and is for intravenous use only. It needs to be stored at a temperature below -15°C (<5°F). The package insert contains directions for use. The medication is manufactured by Emergent BioSolutions Canada Inc. and distributed by the Centers for Disease Control and Prevention. The label includes information for potency, lot number, fill volume, and expiry date. BAT® is a trademark of Emergent BioSolutions Inc.*

FDA Label Image

20cc Carton Label (Image 03)

This is a description of a medication called BAT® (Botulism Antitoxin Heptavalent) designed for intravenous use. It contains no preservatives and is used only in select emergency situations. The medication comes in a package of 24 vials and has different potency levels for each serotype. The medication is distributed by the Centers for Disease Control and Prevention and is a trademark of Emergent BioSolutions Inc. Manufacturing is done in Canada. More detailed information can be found in the package insert.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.